BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9757958)

  • 1. Further evidence that the WT1 gene does not have a role in the development of the derivatives of the müllerian duct.
    van Lingen BL; Reindollar RH; Davis AJ; Gray MR
    Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 1):597-603. PubMed ID: 9757958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role for anti-Müllerian hormone in congenital absence of the uterus and vagina.
    Resendes BL; Sohn SH; Stelling JR; Tineo R; Davis AJ; Gray MR; Reindollar RH
    Am J Med Genet; 2001 Jan; 98(2):129-36. PubMed ID: 11223848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HOXA10 mutations in congenital absence of uterus and vagina.
    Lalwani S; Wu HH; Reindollar RH; Gray MR
    Fertil Steril; 2008 Feb; 89(2):325-30. PubMed ID: 17482600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral Wilms tumor in a boy with severe hypospadias and cryptochidism due to a heterozygous mutation in the WT1 gene.
    Köhler B; Schumacher V; Schulte-Overberg U; Biewald W; Lennert T; l'Allemand D; Royer-Pokora B; Grüters A
    Pediatr Res; 1999 Feb; 45(2):187-90. PubMed ID: 10022588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mutations in the TP63 gene are potentially associated with Müllerian duct anomalies.
    Wang X; Zhang X; Liu S; Li G; Cui L; Qin Y; Chen ZJ
    Hum Reprod; 2016 Dec; 31(12):2865-2871. PubMed ID: 27798044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in SRY and WT1 genes required for gonadal development are not responsible for XY partial gonadal dysgenesis.
    Tagliarini EB; Assumpção JG; Scolfaro MR; Mello MP; Maciel-Guerra AT; Guerra Júnior G; Hackel C
    Braz J Med Biol Res; 2005 Jan; 38(1):17-25. PubMed ID: 15665984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The embryologic development of the human vagina.
    Ulfelder H; Robboy SJ
    Am J Obstet Gynecol; 1976 Dec; 126(7):769-76. PubMed ID: 1033667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Wilms tumour gene, WT1, in normal and abnormal nephrogenesis.
    Pritchard-Jones K
    Pediatr Nephrol; 1999 Sep; 13(7):620-5. PubMed ID: 10460515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wilms' tumor protein Wt1 is an activator of the anti-Müllerian hormone receptor gene Amhr2.
    Klattig J; Sierig R; Kruspe D; Besenbeck B; Englert C
    Mol Cell Biol; 2007 Jun; 27(12):4355-64. PubMed ID: 17420277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wilms' tumor suppressor gene WT1: from structure to renal pathophysiologic features.
    Mrowka C; Schedl A
    J Am Soc Nephrol; 2000 Nov; 11 Suppl 16():S106-15. PubMed ID: 11065340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
    Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
    Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
    Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype/phenotype correlations in Wilms' tumor.
    Huff V
    Med Pediatr Oncol; 1996 Nov; 27(5):408-14. PubMed ID: 8827067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Wilms tumor 1 (WT1) in the transcriptional regulation of the Mullerian-inhibiting substance promoter.
    Hossain A; Saunders GF
    Biol Reprod; 2003 Dec; 69(6):1808-14. PubMed ID: 12855602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines.
    Algar EM; Khromykh T; Smith SI; Blackburn DM; Bryson GJ; Smith PJ
    Oncogene; 1996 Mar; 12(5):1005-14. PubMed ID: 8649791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-specific regulation of the WT1 locus.
    Hewitt JA; Kessler PM; Campbell CE; Williams BR
    Med Pediatr Oncol; 1996 Nov; 27(5):456-61. PubMed ID: 8827074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways.
    Wang ZY; Qiu QQ; Huang J; Gurrieri M; Deuel TF
    Oncogene; 1995 Feb; 10(3):415-22. PubMed ID: 7845666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the Wilms' tumour gene WT1 in the developing human and in paediatric renal tumours: an immunohistochemical study.
    Charles AK; Mall S; Watson J; Berry PJ
    Mol Pathol; 1997 Jun; 50(3):138-44. PubMed ID: 9292148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N314D polymorphism of the GALT gene is not associated with congenital absence of the uterus and vagina.
    Klipstein S; Bhagavath B; Topipat C; Sasur L; Reindollar RH; Gray MR
    Mol Hum Reprod; 2003 Mar; 9(3):171-4. PubMed ID: 12606594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital absence of uterus and vagina; case report.
    DAVIS CD
    Bull Mason Clin; 1949 Jun; 3(2):35-8. PubMed ID: 18150220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.